Vasoconstriction and the efficacy of hemoglobin-based blood substitutes.

Suppr

超能文献

作者信息

Winslow R M

机构信息

University of California, San Diego Veterans Affairs Medical Center 92161.

出版信息

Transfus Clin Biol. 1994;1(1):9-14. doi: 10.1016/s1246-7820(05)80050-3.

DOI:10.1016/s1246-7820(05)80050-3

PMID:8186857

Abstract

摘要

相似文献

Vasoconstriction and the efficacy of hemoglobin-based blood substitutes.

Transfus Clin Biol. 1994;1(1):9-14. doi: 10.1016/s1246-7820(05)80050-3.

Hemoglobin-based red blood cell substitutes and nitric oxide.

Trends Cardiovasc Med. 2009 Apr;19(3):103-7. doi: 10.1016/j.tcm.2009.06.004.

Artificial Oxygen Carriers.

Artif Organs. 2017 Apr;41(4):311. doi: 10.1111/aor.12946.

Nitroglycerin attenuates vasoconstriction of HBOC-201 during hemorrhagic shock resuscitation.

Resuscitation. 2010 Apr;81(4):481-7. doi: 10.1016/j.resuscitation.2009.12.015. Epub 2010 Jan 18.

Current status of artificial oxygen carriers.

Adv Drug Deliv Rev. 2000 Feb 28;40(3):143-51. doi: 10.1016/s0169-409x(99)00046-0.

Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage.

J Am Coll Surg. 2004 Nov;199(5):693-701. doi: 10.1016/j.jamcollsurg.2004.07.025.

Complement-mediated acute effects of liposome-encapsulated hemoglobin.

Artif Cells Blood Substit Immobil Biotechnol. 1999 Jan;27(1):23-41. doi: 10.3109/10731199909117481.

Studies on blood substitutes based on hemoglobin and perfluorocarbon.

Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):1013-20. doi: 10.3109/10731199209119755.

PEG-hemoglobin: an efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models.

Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):795-803. doi: 10.3109/10731199409117913.

Resuscitation and the limited utility of the present generation of blood substitutes.

Transfus Med Rev. 1996 Oct;10(4):276-85. doi: 10.1016/s0887-7963(96)80003-4.

引用本文的文献

Coadministration of PEGylated apohemoglobin and haptoglobin can limit vascular dysfunction in the microcirculation and prevent acute inflammation.

J Appl Physiol (1985). 2024 Oct 1;137(4):934-944. doi: 10.1152/japplphysiol.00315.2024. Epub 2024 Aug 15.

Examining and mitigating acellular hemoglobin vasoactivity.

Antioxid Redox Signal. 2013 Jun 10;18(17):2329-41. doi: 10.1089/ars.2012.4922. Epub 2012 Oct 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Vasoconstriction and the efficacy of hemoglobin-based blood substitutes.

Transfus Clin Biol. 1994;1(1):9-14. doi: 10.1016/s1246-7820(05)80050-3.

Hemoglobin-based red blood cell substitutes and nitric oxide.

Trends Cardiovasc Med. 2009 Apr;19(3):103-7. doi: 10.1016/j.tcm.2009.06.004.

Artificial Oxygen Carriers.

Artif Organs. 2017 Apr;41(4):311. doi: 10.1111/aor.12946.

Nitroglycerin attenuates vasoconstriction of HBOC-201 during hemorrhagic shock resuscitation.

Resuscitation. 2010 Apr;81(4):481-7. doi: 10.1016/j.resuscitation.2009.12.015. Epub 2010 Jan 18.

Current status of artificial oxygen carriers.

Adv Drug Deliv Rev. 2000 Feb 28;40(3):143-51. doi: 10.1016/s0169-409x(99)00046-0.

Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage.

J Am Coll Surg. 2004 Nov;199(5):693-701. doi: 10.1016/j.jamcollsurg.2004.07.025.

Complement-mediated acute effects of liposome-encapsulated hemoglobin.

Artif Cells Blood Substit Immobil Biotechnol. 1999 Jan;27(1):23-41. doi: 10.3109/10731199909117481.

Studies on blood substitutes based on hemoglobin and perfluorocarbon.

Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):1013-20. doi: 10.3109/10731199209119755.

PEG-hemoglobin: an efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models.

Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):795-803. doi: 10.3109/10731199409117913.

Resuscitation and the limited utility of the present generation of blood substitutes.

Transfus Med Rev. 1996 Oct;10(4):276-85. doi: 10.1016/s0887-7963(96)80003-4.

引用本文的文献

Coadministration of PEGylated apohemoglobin and haptoglobin can limit vascular dysfunction in the microcirculation and prevent acute inflammation.

J Appl Physiol (1985). 2024 Oct 1;137(4):934-944. doi: 10.1152/japplphysiol.00315.2024. Epub 2024 Aug 15.

Examining and mitigating acellular hemoglobin vasoactivity.

Antioxid Redox Signal. 2013 Jun 10;18(17):2329-41. doi: 10.1089/ars.2012.4922. Epub 2012 Oct 11.